Question from Deputy Duncan Smith - PQ 70202-25
Deputy Smith asked about the decision regarding the medicine daridoxerant (quviviq). Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy Smith asked about the decision regarding the medicine daridoxerant (quviviq). Read the HSE response.
Deputy Dolan asked about the measures being taken to ensure equitable access to allergy diagnostics and treatments. Read the HSE response.
Deputy McGreehan asked about access to specialist Parkinson’s disease nurses. Read the HSE response.
Deputy Fleming asked about the extension and upgrading of Mountrath Health Centre, Mountrath, Laois. Read the HSE response.
Deputy O'Gorman asked about the strategy for dealing with long-Covid. Read the HSE response.
Deputy McGreehan asked about the applications received under the endometriosis surgery abroad interim scheme (ESAIS). Read the HSE response.
Deputy McGreehan asked about an assessment of whether the reliance on the endometriosis surgery abroad interim scheme (ESAIS). Read the HSE response.
Deputy O'Flynn asked for the number of applications approved under the treatment abroad scheme for gender-affirming surgery. Read the HSE response.
Deputy Farrell the approval of dupilumab for the treatment of paediatric eosinophilic oesophagitis. Read the HSE response.
Deputy McGreehan asked about actions being taken to increase public awareness of sun-safety and UV risks. Read the HSE response.